We are live on
!
Find out more
KXA
KPCB XVI Associates Portfolio holdings
AUM
$225M
1-Year Est. Return
26.26%
This Fund
S&P 500
This Quarter
Est. Return
-33.18%
1 Year Est. Return
-26.26%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$225M
AUM Growth
+$7.35M
(+3.4%)
Cap. Flow
+$128M
Cap. Flow
% of AUM
56.92%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
3
New
1
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AEye
LIDR
|
+$128M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 55.86% |
| 2 | Technology | 33.77% |
| 3 | Healthcare | 10.38% |
Similar funds
LFF
SCDF
SMR
CPWM
CP
PP
PEA
MCL
KPCB XVI Associates's Q3 2021 Portfolio in Review
As of Q3 2021, KPCB XVI Associates held 3 positions worth $225M, up 3.4% from $217M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
KPCB XVI Associates deployed $128M of net new capital in Q3 2021, opening 1 new position. Its largest new stake was AEye: 462,136 shares worth $75.8M.
By sector, the portfolio is most concentrated in Industrials at 56% of assets, down from 93% a quarter earlier, followed by Technology and Healthcare.
- KPCB XVI Associates's largest Q3 2021 buy was AEye: 462,136 shares worth $75.8M.
- KPCB XVI Associates's ten largest holdings make up 100% of its $225M portfolio in Q3 2021.
- KPCB XVI Associates opened 1 new position and closed 0 in Q3 2021.
- KPCB XVI Associates's portfolio value rose 3.4% quarter-over-quarter to $225M.
Based on KPCB XVI Associates's 13F filing for Q3 2021, filed 25 Oct 2021.